Background: Tuberculosis (TB) in children is frequently paucibacillary and non-severe forms of pulmonary TB are common. Evidence for tuberculosis treatment in children is largely extrapolated from adult studies. Trials in adults with smear-negative tuberculosis suggest that treatment can be effectively shortened from 6 to 4 months. New paediatric, fixed-dose combination anti-tuberculosis treatments have recently been introduced in many countries, making the implementation of World Health Organisation (WHO)-revised dosing recommendations feasible. The safety and efficacy of these higher drug doses has not been systematically assessed in large studies in children, and the pharmacokinetics across children representing the range of weights and ...
BACKGROUND: Two thirds of children with tuberculosis have nonsevere disease, which may be treatable ...
In South Africa, a country with one of the highest levels of HIV prevalence, HIV-positive adults are...
Background Multidrug-resistant (MDR) tuberculosis (TB) presents a challenge for global TB control. ...
Background: Tuberculosis (TB) is the deadliest infectious disease globally, with 10.4 million people...
Tuberculosis (TB) is among the top 10 causes of death among children worldwide; however, children wi...
Background: Tuberculosis (TB) in children is frequently paucibacillary and non-severe forms of pulmo...
BACKGROUND: Tuberculosis (TB) in children is frequently paucibacillary and non-severe forms of pulmo...
BACKGROUND: Tuberculosis (TB) in children is frequently paucibacillary and non-severe forms of pulmo...
CITATION: Chabala, C., et al. 2018. Shorter treatment for minimal tuberculosis (TB) in children (SHI...
Young children are most vulnerable to develop severe forms of tuberculosis (TB) and are over-represe...
Background: Two thirds of children with tuberculosis have nonsevere disease, which may be treatable ...
Background The global burden of childhood tuberculosis (TB) is estimated to be 0.5 million new cases...
Introduction: Tuberculosis is the second leading cause of death from an infectious cause worldwide h...
BACKGROUND: Multidrug-resistant (MDR) tuberculosis (TB) presents a challenge for global TB control. ...
Children suffer a huge burden of disease in tuberculosis (TB) endemic countries. This disease burden...
BACKGROUND: Two thirds of children with tuberculosis have nonsevere disease, which may be treatable ...
In South Africa, a country with one of the highest levels of HIV prevalence, HIV-positive adults are...
Background Multidrug-resistant (MDR) tuberculosis (TB) presents a challenge for global TB control. ...
Background: Tuberculosis (TB) is the deadliest infectious disease globally, with 10.4 million people...
Tuberculosis (TB) is among the top 10 causes of death among children worldwide; however, children wi...
Background: Tuberculosis (TB) in children is frequently paucibacillary and non-severe forms of pulmo...
BACKGROUND: Tuberculosis (TB) in children is frequently paucibacillary and non-severe forms of pulmo...
BACKGROUND: Tuberculosis (TB) in children is frequently paucibacillary and non-severe forms of pulmo...
CITATION: Chabala, C., et al. 2018. Shorter treatment for minimal tuberculosis (TB) in children (SHI...
Young children are most vulnerable to develop severe forms of tuberculosis (TB) and are over-represe...
Background: Two thirds of children with tuberculosis have nonsevere disease, which may be treatable ...
Background The global burden of childhood tuberculosis (TB) is estimated to be 0.5 million new cases...
Introduction: Tuberculosis is the second leading cause of death from an infectious cause worldwide h...
BACKGROUND: Multidrug-resistant (MDR) tuberculosis (TB) presents a challenge for global TB control. ...
Children suffer a huge burden of disease in tuberculosis (TB) endemic countries. This disease burden...
BACKGROUND: Two thirds of children with tuberculosis have nonsevere disease, which may be treatable ...
In South Africa, a country with one of the highest levels of HIV prevalence, HIV-positive adults are...
Background Multidrug-resistant (MDR) tuberculosis (TB) presents a challenge for global TB control. ...